Page last updated: 2024-09-05

1,3-dipropylxanthine and n(6)-cyclopentyladenosine

1,3-dipropylxanthine has been researched along with n(6)-cyclopentyladenosine in 2 studies

Compound Research Comparison

Studies (1,3-dipropylxanthine)	Trials (1,3-dipropylxanthine)	Recent Studies (post-2010) (1,3-dipropylxanthine)	Studies (n(6)-cyclopentyladenosine)	Trials (n(6)-cyclopentyladenosine)	Recent Studies (post-2010) (n(6)-cyclopentyladenosine)
26	0	0	605	0	62

Protein Interaction Comparison

Protein	Taxonomy	n(6)-cyclopentyladenosine (IC50)
Adenosine receptor A1	Rattus norvegicus (Norway rat)	0.2256
Adenosine receptor A2b	Rattus norvegicus (Norway rat)	1.16
Adenosine receptor A1	Homo sapiens (human)	0.0027
Adenosine receptor A2a	Rattus norvegicus (Norway rat)	1.16

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishii, A; Nonaka, H; Shimada, J; Suzuki, F	1
Figler, H; Jin, X; Linden, J; Robeva, AS; Thai, T	1

Other Studies

2 other study(ies) available for 1,3-dipropylxanthine and n(6)-cyclopentyladenosine

Article	Year
8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors. Journal of medicinal chemistry, 1992, Mar-06, Volume: 35, Issue:5 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cell Membrane; Corpus Striatum; Guinea Pigs; Humans; Molecular Conformation; Molecular Structure; Prosencephalon; Purinergic Antagonists; Rats; Receptors, Purinergic; Stereoisomerism; Structure-Activity Relationship; Xanthines	1992
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Molecular pharmacology, 1999, Volume: 56, Issue:4 Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines	1999

Article

Year

8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.

Journal of medicinal chemistry, 1992, Mar-06, Volume: 35, Issue:5

Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cell Membrane; Corpus Striatum; Guinea Pigs; Humans; Molecular Conformation; Molecular Structure; Prosencephalon; Purinergic Antagonists; Rats; Receptors, Purinergic; Stereoisomerism; Structure-Activity Relationship; Xanthines

1992

Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.

Molecular pharmacology, 1999, Volume: 56, Issue:4

Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines

1999